Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-705-7 | CAS number: 1228186-15-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2002-06-19 to 2002-08-22
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, chlorides
- EC Number:
- 263-082-9
- EC Name:
- Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, chlorides
- Cas Number:
- 61789-73-9
- IUPAC Name:
- 61789-73-9
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, Kreuzelweg 53, 5961 NM Horst, PO box 6174 NL, 5960 Ad Horst, The Netherlands
- Age at study initiation: 4-5 weeks
- Weight at study initiation: 250-300 g
- Housing: During acclimatisation, animals were housed in groups of up to 10, and during the study in groups of up to 5, in suspended stainless steel cages with a grid floor.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±2°C
- Humidity (%): 55±15%.
- Air changes (per hr): 15-20 air changes per hour.
- Photoperiod: 12hrs dark / 12hrs light):
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Main study:
-Induction:
intradermal injection: 0.5% w/v in sterile water.
topical application: 10% w/v in sterile water.
-Challenge:
10% and 1% w/v in sterile water
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Main study:
-Induction:
intradermal injection: 0.5% w/v in sterile water.
topical application: 10% w/v in sterile water.
-Challenge:
10% and 1% w/v in sterile water
- No. of animals per dose:
- In the preliminary study: 7 animals.
In the main study, test group of 20 animals and a control group of 10. - Details on study design:
- RANGE FINDING TESTS: conducted to define the concentrations to be tested in the main study
-Intradermal exposure:
Hair over the scapulae was removed using electric clippers before treatment.
Intradermal administration of 0.1 ml of the test material (TM) at increasing concentrations. Concentrations of 50%, 20%, 10%, 5%, 1% and 0.5% in sterile water were selected but only the lower concentrations of 5%, 1% and 0.5% could be injected due to the high density of the preparations.
Evalauation of the potential cutaneous reactions: 6 days later
- Epicutaneousexposure:
Hair over the scapulae was removed using electric clippers before treatment.
0.2ml of each selected concentration applied to a gauze patch measuring 2x2cm for 24 hours under occlusive dressing (2 concentrations per animal). A total of 5 concentrations (50%, 20%, 10%, 5%, 1% and 0.5% in sterile water) were tested in duplicate.
Evaluation of the potential cutaneous reactions 24 and 48 hours after patch removal.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1 intradermal, 1 epicutaneous
- Exposure period: epicutaneous: 48 hours
-> TEST GROUPS:
Intradermal exposure
Three injections of 0.1 mL were injected into each side of the animal as follows:
. Freund's complete adjuvant (FCA) diluted to 50% with sterile water
. TM at 0.5 % w/v in vehicle
. TM at 0.5% w/v in a 50/50 (v/v) mixture of FCA and sterile water
Epicutaneous exposure
Application of 2 x 2cm patch saturated with 0.4 ml of the TM at 10% w/v in sterile water applied to the scapular region and held in place for 48 hours using an occlusive dressing.
-> CONTROL GROUP:
Intradermal exposure
Three injections of 0.1 mL were injected into each side of the animal as follows:
. Freund's complete adjuvant (FCA) diluted to 50% with sterile water
. vehicle
. A mixture 50/50 (v/v) FCA diluted to 50% with sterile water, and vehicle
Epicutaneous exposure
Application of 2 x 2cm patch saturated with 0.4 ml of the vehicule applied to the scapular region and held in place for 48 hours using an occlusive dressing.
- Site:
Intradermal exposure
6 injections in the clipped area (2x 4cm) in the scapular region
Epicutaneous exposure
2x 2cm area over the scapulae
- Frequency of applications:
One intradermal injection and one epicutaneous application 7 days (Day 8 of the study) after on the same site.
- Duration:
Epicutaneous exposure: 48 hours
B. CHALLENGE EXPOSURE
- No. of exposures: 2 ( the animals were re-challenged at a lower concentration since a response to the first challenge was noted in a number of animals in both the control and tests groups)
- Day(s) of challenge: 22 and 29
- Exposure period: 24 hours
-> TEST GROUPS:
First challenge: 0.2 mL of the TM at 10% w/v in sterile water on the right flank and 0.2 mL of the vehicule to the left flank (occlusive epicutaneous application)
Second challenge: 0.2 mL of the TM at 1% w/v in sterile water on the right flank and 0.2 mL of the vehicule to the left flank (occlusive epicutaneous application)
-> CONTROL GROUPS:
Same treatment as test group
- Site: anterior and posterior left flank
- Evaluation (hr after challenge): 24 , 48 hours after removal of the dressing according to the method of Draize. - Challenge controls:
- Yes - see above.
- Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamalaldehyde
Study design: in vivo (LLNA)
- Statistics:
- None
Results and discussion
- Positive control results:
- Regular checks are performed at the laboratory with the positive control substance alpha-hexylcinnamalaldehyde. The most recent reliability check achieved a 100% response in the test group and 0% response in the control group at challenge.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- challenged with Test material 10% w/v in sterile water
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Clinical observations:
- 7 and 1 animals with erythema grade 1 and 2 respectively.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: challenged with Test material 10% w/v in sterile water. No with. + reactions: 8.0. Total no. in groups: 10.0. Clinical observations: 7 and 1 animals with erythema grade 1 and 2 respectively..
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- challenged with Test material 10% w/v in sterile water
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- 5 and 1 animals with erythema grade 1 and 2 respectively.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: challenged with Test material 10% w/v in sterile water. No with. + reactions: 6.0. Total no. in groups: 10.0. Clinical observations: 5 and 1 animals with erythema grade 1 and 2 respectively..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- challenged with Test material 10% w/v in sterile water
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- 15 and 5 animals with erythema grade 1 and 2 respectively.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: challenged with Test material 10% w/v in sterile water. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: 15 and 5 animals with erythema grade 1 and 2 respectively..
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- challenged with Test material 10% w/v in sterile water
- No. with + reactions:
- 13
- Total no. in group:
- 20
- Clinical observations:
- 10 and 3 animals with erythema grade 1 and 2 respectively. Desquamation was noted in 6 animals.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: challenged with Test material 10% w/v in sterile water. No with. + reactions: 13.0. Total no. in groups: 20.0. Clinical observations: 10 and 3 animals with erythema grade 1 and 2 respectively. Desquamation was noted in 6 animals..
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- challenged with Test material 1% w/v in sterile water
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: challenged with Test material 1% w/v in sterile water. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- challenged with Test material 1% w/v in sterile water
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: challenged with Test material 1% w/v in sterile water. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- challenged with Test material 1% w/v in sterile water
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: challenged with Test material 1% w/v in sterile water. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- challenged with Test material 1% w/v in sterile water
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: challenged with Test material 1% w/v in sterile water. No with. + reactions: 0.0. Total no. in groups: 20.0.
Any other information on results incl. tables
The preliminary study indicated that the test material injected at 0.5% concentration was reasonably well tolerated. A concentration of 10% was selected for the topical induction as it was judged to be well tolerated and non-irritant. A response to treatment was noted in a number of animals in both the control and test groups so a re-challenge at the lower concentration of 1% was performed.
Table 1: Challenge responses
|
Group |
Treatment |
Incidence of response (%) at challenge |
|
24 hours |
48 hours |
|||
First challenge |
Control |
10% Test material |
80% |
60% |
Vehicle |
0% |
0% |
||
Test |
10% Test material |
100% |
65% |
|
Vehicle |
0% |
0% |
||
Second challenge |
Control |
1% Test material |
0% |
0% |
Vehicle |
0% |
0% |
||
Test |
1% Test material |
0% |
0% |
|
Vehicle |
0% |
0% |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- There was no reaction observed at challenge with 1% test material concentration.Under these experimental conditions and according to the criteria laid down in CLP (Reg 1272/2008/EC) and directive 67/548/EEC, the substance does not induce delayed contact hypersensitivity and is not classified.
- Executive summary:
The potential of the substance to induce delayed contact hypersensitivity was assessed in guinea pigs according to OECD guideline 406 and in compliance with the principles of the Good Laboratory practice regulations.
The induction phase was realized both by intradermal route on day 1 (Test material 0.5 % w/v in sterile water) and by cutaneous route on day 8 (Test material 10% w/v in sterile water ) in 2 groups of guinea pigs: 10 females for control group and 20 females for treated group. The challenge phase was realized on day 22 by cutaneous application of the test material at 10% w/v in sterile water. The cutaneous reactions were scored 24 and 48 after the challenge phase. As a response to treatment was noted in a number of animals in both the control and test groups, a re-challenge at the lower concentration of 1% was performed on day 29.
The first challenge application with 10% w/v of the test material in sterile water resulted in very slight to well defined erythema in the majority of animals of both test and control groups (6/10 and 13/20 at the 48-hour reading respectively). No reaction was noted to the vehicle alone. The presence of reaction in both test and control group animals indicated an irritant response to treatment rather than sensitisation. This was investigated by repeating the challenge with a lower concentration of 1% one week later. On this occasion, no response was observed in any animal of the test or control groups following 24 hours topical exposure. Again, no reaction to the vehicle alone was observed.
It was concluded that the substance does not elicit a sensitisation response in the guinea pig.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
